Results 31 to 40 of about 9,499,844 (341)

Sarcopenia in patients with rheumatic musculoskeletal diseases

International Journal of Rheumatic Diseases, 2023
To investigate the impact of high‐dose glucocorticoid therapy on sarcopenia in hospitalized patients with rheumatic musculoskeletal diseases (RMDs).
H. Hanaoka, J. Kikuchi, K. Hiramoto, M. Akiyama, S. Saito, Y. Kondo, Y. Kaneko   +6 more
semanticscholar   +1 more source

Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?

Biomedicines, 2022
(1) Background: We explored, for the first time, the contribution of angiogenic T cells (TAng) in interstitial lung disease associated to autoimmune disease (AD-ILD+) as potential biomarkers of the disease, evaluating their role in the underlying ...
Verónica Pulito-Cueto, Sara Remuzgo-Martínez, Fernanda Genre, Belén Atienza-Mateo, Víctor M. Mora-Cuesta, David Iturbe-Fernández, Leticia Lera-Gómez, Javier Rodriguez-Carrio, Diana Prieto-Peña, Virginia Portilla, Ricardo Blanco, Alfonso Corrales, Oreste Gualillo, José M. Cifrián, Raquel López-Mejías, Miguel A. González-Gay   +15 more
doaj   +1 more source

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

Arthritis & Rheumatology, 2022
To provide guidance to rheumatology providers on the use of COVID‐19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).
J. Curtis, S. Johnson, Dona Anthony, R. Arasaratnam, L. Baden, A. Bass, C. Calabrese, E. Gravallese, R. Harpaz, Andrew T. Kroger, R. Sadun, Amy S. Turner, E. Williams, T. Mikuls   +13 more
semanticscholar   +1 more source

Incidence of Unrecognized Incidental Durotomy during Surgery for Malignant Spinal Tumor

Spine Surgery and Related Research, 2020
Introduction: Cerebral spinal fluid leak from durotomy is a well-known risk with spinal surgeries. The aim of this study is to identify the incidence of unrecognized incidental durotomy during posterior surgery for spinal metastases and its risk factors.
Takuma Koyama, Shurei Sugita, Takahiro Hozumi, Masanori Fujiwara, Kiyofumi Yamakawa, Tomotake Okuma, Takahiro Goto   +6 more
doaj   +1 more source

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases, 2022
Background Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring.
A. de Thurah, P. Bosch, A. Marques, Y. Meissner, C. Mukhtyar, J. Knitza, A. Najm, N. Østerås, T. Pelle, L. Knudsen, H. Šmucrová, F. Berenbaum, M. Jani, R. Geenen, M. Krusche, P. Pchelnikova, Savia de Souza, S. Badreh, D. Wiek, S. Piantoni, J. Gwinnutt, C. Duftner, H. Canhão, L. Quartuccio, N. Stoilov, Yeliz Prior, J. Bijlsma, A. Zabotti, T. Stamm, C. Dejaco   +29 more
semanticscholar   +1 more source

OA01 Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry

Rheumatology, 2022
Background/Aims People with inflammatory/autoimmune rheumatic and musculoskeletal diseases (I-RMDs) were excluded from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccine clinical development programmes; therefore, concerns regarding the
P. Machado, S. Lawson-Tovey, A. Strangfeld, E. Mateus, K. Hyrich, L. Gossec, L. Carmona, A. Rodrigues, B. Raffeiner, C. Duarte, E. Hachulla, E. Veillard, E. Straková, G. Burmester, G. Yardimci, J. Gómez-Puerta, J. Zepa, L. Kearsley‐Fleet, L. Trefond, M. Cunha, M. Mosca, M. Cornalba, M. Soubrier, N. Roux, O. Brocq, P. Durez, R. Conway, T. Goulenok, J. Bijlsma, I. McInnes, X. Mariette   +30 more
semanticscholar   +1 more source

Modulation of Microglia by Voluntary Exercise or CSF1R Inhibition Prevents Age-Related Loss of Functional Motor Units

Cell Reports, 2019
Summary: Age-related loss of skeletal muscle innervation by motor neurons leads to impaired neuromuscular function and is a well-established clinical phenomenon. However, the underlying pathogenesis remains unclear. Studying mice, we find that the number
Elisa Giorgetti, Moh Panesar, Yunyu Zhang, Stefanie Joller, Marie Ronco, Michael Obrecht, Christian Lambert, Nathalie Accart, Nicolau Beckmann, Arno Doelemeyer, Ludovic Perrot, Isabelle Fruh, Matthias Mueller, Eliane Pierrel, Serge Summermatter, Michael Bidinosti, Derya R. Shimshek, Sophie Brachat, Mark Nash   +18 more
doaj   +1 more source

Effects and Mechanisms of Polyunsaturated Fatty Acids on Age-Related Musculoskeletal Diseases: Sarcopenia, Osteoporosis, and Osteoarthritis-A Narrative Review. [PDF]

Nutrients
Background: The process of the globally aging population has been accelerating, leading to an increasing social burden. As people age, the musculoskeletal system will gradually go through a series of degenerative and loss of function and eventually ...
Chen H, Xiong R, Cheng J, Ye J, Qiu Y, Huang S, Li M, Liu Z, Pang J, Zhang X, Guo S, Li H, Zhu H.   +12 more
europepmc   +2 more sources

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4

Arthritis & Rheumatology, 2022
To provide guidance to rheumatology providers on the use of COVID‐19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).
J. Curtis, S. Johnson, Dona Anthony, R. Arasaratnam, L. Baden, A. Bass, C. Calabrese, E. Gravallese, R. Harpaz, Andrew T. Kroger, R. Sadun, Amy S. Turner, E. Williams, T. Mikuls   +13 more
semanticscholar   +1 more source

EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases, 2022
Objective To develop EULAR points-to-consider for therapeutic drug monitoring (TDM) of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases (RMDs).
C. Krieckaert, A. V. van Tubergen, J. Gehin, B. Hernández-Breijo, G. le Mélédo, A. Balsa, P. Böhm, S. Čučnik, O. Elkayam, G. Goll, F. Hooijberg, M. Jani, P. Kiely, Neil McCarthy, D. Mulleman, V. Navarro-Compán, K. Payne, M. Perry, C. Plasencia-Rodríguez, S. Stones, S. W. Syversen, A. de Vries, Katherine M Ward, G. Wolbink, J. Isaacs   +24 more
semanticscholar   +1 more source